Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Rises By 905.4%

HCW Biologics Inc. (NASDAQ:HCWB) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 835,500 shares, an increase of 905.4% from the January 31st total of 83,100 shares. Based on an average trading volume of 6,100,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 3.6% of the company’s stock are short sold.

HCW Biologics Price Performance

Shares of HCWB opened at $0.38 on Friday. The company has a market capitalization of $16.88 million, a price-to-earnings ratio of -0.38 and a beta of 0.81. The business’s 50-day moving average is $0.39 and its 200-day moving average is $0.47. HCW Biologics has a fifty-two week low of $0.21 and a fifty-two week high of $2.52.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.